Labetuzumab (Anti-CEACAM5 / CEA / CD66e)
A2638
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NameLabetuzumab (Anti-CEACAM5 / CEA / CD66e)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionLabetuzumab (Anti-CEACAM5 / CEA / CD66e) is a humanised monoclonal antibody targeting carcinoembryonic antigen (CEA). It inhibits tumour growth and sensitises human medullary thyroid cancer xenografts to Dacarbazine chemotherapy. MW :145.36 KD.
- Storage Instruction-20°C
- UNSPSC12352203